
Carbon
-Waste
-Water
-Energy
-Revenue
3,481 Million USD
- About Company
-
ESG Performance Data
-
-
Environmental
- Emission Reduction
Feature available only to subscribers.
- Resource Reduction
Feature available only to subscribers.

Energy Use Total Direct Energy Use Indirect Energy Use Electricity Purchased Renewable Energy Use Water Use Total Fresh Water Use Total Water Recycled Environmental Partnerships
-
Social
- Product Responsibility
Feature available only to subscribers.

Customer Health and Safety Tools Quality Tools Responsible R&D Responsible Marketing Product Access Product Quality and Responsibility Internal Audits Product and Services Fines - Community
Feature available only to subscribers.
- Human Rights
Feature available only to subscribers.
- Diversity/Opportunity
Feature available only to subscribers.
- Employment Quality
Feature available only to subscribers.

Generous Fringe Benefits Turnover of Employees Net employment creation - Health/Safety
Feature available only to subscribers.

Total Injury Rate Employee Fatalities Contractor Fatalities Lost Time Injury Rate: Employees and Contractors Lost Time Injury Rate: Employees Only - Training/Development
Feature available only to subscribers.

Training and Career Development Improvement Tools Training and Career Development Progress Surveys University Donations Scholarships Employee Training Hours
-
Governance
- Board Functions
Feature available only to subscribers.
- Board Structure
Feature available only to subscribers.
- Compensation Policy
Feature available only to subscribers.

Performance Oriented Compensation Extra-Financial Performance Oriented Compensation Performance Oriented Compensation Extra-Financial Performance Oriented Compensation - Vision/Strategy
Feature available only to subscribers.
- Stakeholder Rights
Feature available only to subscribers.

Shareholder Rights Equal Voting Rights Proposal Right Voting Procedure Shareholder Rights Governance Report-Years Published
-
Environmental
-
About Company
Shionogi & Company, Limited (TYO: 4507, OSE: 4507) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses Shionogi
The company engages in the manufacture and sale of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical and Related Business segment is engaged in the development, manufacturing and sale of general pharmaceuticals and diagnostic drugs, including vitamin preparations, antipyretics and analgesics, eye care products, cold and sinus medicine, digestive medicine, dermatologic preparations, test paper for glucose in urine and artificial teeth-related products. The Others segment is engaged in the leasing of real estate and the provision of logistics services. As of March 31, 2010, the Company had 17 consolidated subsidiaries and four associated companies.
The company has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.Shionogi had also supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India.
Company Website: www.shionogi.co.jp
Corporate Responsibility Website: Environmental Activities at Shionogi

Subscribe to the
Justmeans ESG Dashboard
A subscription includes full access to Environmental, Social, and Governance Data, company comparisons, ability to share data charts, custom reports, and more.
To subscribe for Justmeans, please contact us at subscribers@justmeans.com to learn more.

- About
- · Advertise
- · RSS
- · Terms & Conditions
- · Policy
- · Contact Us
- · Video
- · Site Map
- · Social Media Conference 2010






